Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The diagnosis of chronic inflammatory demyelinating polyneuropathy: a Delphi-method approach.
Fibroblast Growth Factor-2 Signaling in Neurogenesis and Neurodegeneration.
Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus.
Glio-vascular modifications caused by Aquaporin-4 deletion in the mouse retina.
Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives.
Cord blood mononuclear cells prevent neuronal apoptosis in response to perinatal asphyxia in the newborn lamb.
POEMS Syndrome in a Juvenile Initially Diagnosed as Treatment Resistant Chronic Inflammatory Demyelinating Polyneuropathy.
Disease-related and functional predictors of employment status among adults with multiple sclerosis.
Collateral benefit: the comeback of MOG antibodies as a biomarker in neurological practice.
Protective effect of a germline, IL-17-neutralizing antibody in murine models of autoimmune inflammatory disease.
New opportunities of real world data from clinical routine settings in life cycle-management of drugs: example of an integrative approach in multiple sclerosis.
Epigenetic mechanisms in neurological and neurodegenerative diseases.
Vaccination, infection, and the risk for multiple sclerosis.
Charcot-Marie-Tooth type 1C disease coexisting with progressive multiple sclerosis: a study of an overlapping syndrome.
Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors.
Paradoxical Effect of Cortistatin Treatment and Its Deficiency on Experimental Autoimmune Encephalomyelitis.
Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM Evaluation of: Gold R, Kappos L, Arnold D, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 2012;
Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression.
Diagnostic markers of axonal degeneration and demyelination in sensory nerve conduction.
Spatiotemporal ablation of CXCR2 on oligodendrocyte lineage cells: Role in myelin repair.
The cerebellar channelopathy of multiple sclerosis.
Ocular motor signatures of cognitive dysfunction in multiple sclerosis.
[Foix-Chavany-Marie syndrome presenting as multiple sclerosis].
IL-11 in multiple sclerosis.
Modulation of Immune response by Ultra-violet light in HLA class-II transgenic mice.
Pages
« first
‹ previous
…
605
606
607
608
609
610
611
612
613
…
next ›
last »